Boston Scientific Stock Fundamentals
B1SX34 Stock | BRL 563.16 0.30 0.05% |
Boston Scientific fundamentals help investors to digest information that contributes to Boston Scientific's financial success or failures. It also enables traders to predict the movement of Boston Stock. The fundamental analysis module provides a way to measure Boston Scientific's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Boston Scientific stock.
Boston |
Boston Scientific Company Operating Margin Analysis
Boston Scientific's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Boston Scientific Operating Margin | 0.17 % |
Most of Boston Scientific's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Boston Scientific is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition |
Based on the recorded statements, Boston Scientific has an Operating Margin of 0.1731%. This is 100.49% lower than that of the Healthcare sector and 100.44% lower than that of the Medical Devices industry. The operating margin for all Brazil stocks is 103.14% lower than that of the firm.
Boston Scientific Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Boston Scientific's current stock value. Our valuation model uses many indicators to compare Boston Scientific value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Boston Scientific competition to find correlations between indicators driving Boston Scientific's intrinsic value. More Info.Boston Scientific is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 1.04 of Return On Asset per Return On Equity. Comparative valuation analysis is a catch-all model that can be used if you cannot value Boston Scientific by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Boston Scientific's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Boston Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Boston Scientific's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Boston Scientific could also be used in its relative valuation, which is a method of valuing Boston Scientific by comparing valuation metrics of similar companies.Boston Scientific is currently under evaluation in operating margin category among its peers.
Boston Fundamentals
Return On Equity | 0.0407 | |||
Return On Asset | 0.0425 | |||
Profit Margin | 0.06 % | |||
Operating Margin | 0.17 % | |||
Current Valuation | 405.56 B | |||
Shares Outstanding | 1.43 B | |||
Price To Earning | 53.01 X | |||
Price To Book | 3.82 X | |||
Price To Sales | 28.55 X | |||
Revenue | 11.89 B | |||
Gross Profit | 8.84 B | |||
EBITDA | 2.51 B | |||
Net Income | 1.04 B | |||
Cash And Equivalents | 276 M | |||
Cash Per Share | 0.19 X | |||
Total Debt | 8.79 B | |||
Debt To Equity | 0.54 % | |||
Current Ratio | 1.31 X | |||
Book Value Per Share | 12.32 X | |||
Cash Flow From Operations | 1.87 B | |||
Earnings Per Share | 2.35 X | |||
Price To Earnings To Growth | 2.52 X | |||
Number Of Employees | 10 | |||
Beta | 0.79 | |||
Market Capitalization | 358.52 B | |||
Total Asset | 32.23 B | |||
Z Score | 24.0 | |||
Net Asset | 32.23 B |
About Boston Scientific Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Boston Scientific's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Boston Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Boston Scientific based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts. BOSTON SCIENDRN operates under Medical Devices classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 41000 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Boston Stock
Boston Scientific financial ratios help investors to determine whether Boston Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Boston with respect to the benefits of owning Boston Scientific security.